Hawaiian Business Post
SEE OTHER BRANDS

Hottest business and economy news from Hawaii

Paul Mueller Company Announces Its Third Quarter Earnings of 2025

SPRINGFIELD, Mo., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced earnings for the third quarter ended September 30, 2025.

 
PAUL MUELLER COMPANY
NINE-MONTH REPORT
Unaudited
(In thousands)
CONSOLIDATED STATEMENTS OF INCOME
           
  Three Months Ended
  Nine Months Ended
  Twelve Months Ended
  September 30   September 30   September 30
    2025     2024       2025       2024       2025       2024  
                       
Net Sales $ 61,375   $ 62,085     $ 192,859     $ 178,111     $ 263,333     $ 233,897  
Cost of Sales   45,349     41,028       131,147       121,459       175,812       160,203  
Gross Profit $ 16,026   $ 21,057     $ 61,712     $ 56,652     $ 87,521     $ 73,694  
Selling, General and Administrative Expense   10,298     12,238       35,163       34,013       47,398       85,736  
Operating Income (Loss) $ 5,728   $ 8,819     $ 26,549     $ 22,639     $ 40,123     $ (12,042 )
Interest Expense   (50)     (83 )     (163)       (256 )     (208)       (347 )
Other Income   691     840       1,525       1,885       2,017       2,741  
Income (Loss) before Provision (Benefit) for Income Taxes $ 6,369   $ 9,576     $ 27,911     $ 24,268     $ 41,932     $ (9,648 )
Provision (Benefit) for Income Taxes   1,487     2,297       6,472       5,736       9,353       (4,306 )
Net Income (Loss)       3225 $ 4,882   $ 7,279     $ 21,439     $ 18,532     $ 32,579     $ (5,342 )
                       
Earnings (Loss) per Common Share -         Basic and Diluted $ 5.25   $ 7.77     $ 23.00     $ 18.79     $ 34.90     $ (5.28 )
                       


       
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
               
  Nine Months Ended
  September 30
    2025       2024  
       
Net Income $ 21,439     $ 18,532  
Other Comprehensive Income (Loss), Net of Tax:      
Foreign Currency Translation Adjustment   3,166       526  
Comprehensive Income $ 24,605     $ 19,058  
       


 
CONSOLIDATED BALANCE SHEETS
       
  September 30   December 31  
    2025       2024  
       
Cash and Cash Equivalents $ 13,812     $ 21,169  
Marketable Securities   28,345       24,446  
Accounts Receivable   39,460       31,266  
Inventories (FIFO)   48,859       40,905  
LIFO Reserve   (21,460 )     (20,146 )
Inventories (LIFO)   27,399       20,759  
Current Net Investments in Sales-Type Leases   57       39  
Other Current Assets   9,918       4,933  
Current Assets $ 118,991     $ 102,612  
       
Net Property, Plant, and Equipment   68,279       50,754  
Right of Use Assets   2,403       2,235  
Other Assets   1,767       1,862  
Long-Term Net Investments in Sales-Type Leases   1,590       1,211  
Total Assets $ 193,030     $ 158,674  
       
Accounts Payable $ 17,462     $ 17,588  
Current Maturities and Short-Term Debt   468       3,466  
Current Lease Liabilities   412       336  
Advance Billings   39,400       26,788  
Other Current Liabilities   27,237       23,226  
Current Liabilities $ 84,979     $ 71,404  
       
Long-Term Debt   5,382       5,096  
Long-Term Pension Liabilities   -       -  
Other Long-Term Liabilities   691       2,329  
Lease Liabilities   977       896  
Total Liabilities $ 92,029     $ 79,725  
Shareholders' Investment   101,001       78,949  
Total Liabilities and Shareholders' Investment $ 193,030     $ 158,674  
       


 
SELECTED FINANCIAL DATA
       
  September 30   December 31
    2025       2024  
Book Value per Common Share $ 108.62     $ 84.27  
Total Shares Outstanding   929,883       936,837  
Backlog $ 250,448     $ 153,685  
       


                       
CONSOLIDATED STATEMENT OF SHAREHOLDERS' INVESTMENT
                  Accumulated Other Comprehensive Income (Loss)    
                     
  Common Stock   Paid-in Surplus       Treasury Stock      
      Retained Earnings       Total
Balance, December 31, 2024 $ 1,508   $ 9,708     $ 96,037     $ (22,697 )   $ (5,607 )   $ 78,949  
Add (Deduct):                      
Net Income           21,439               21,439  
Other Comprehensive Income (Loss), Net of Tax                   3,166       3,166  
Dividends           (774 )             (774 )
Treasury Stock Acquisition               (1,779 )         (1,779 )
Other                       -  
Balance, September 30, 2025 $ 1,508   $ 9,708     $ 116,702     $ (24,476 )   $ (2,441 )   $ 101,001  
                       


 
       
CONSOLIDATED STATEMENT OF CASH FLOWS
  Nine Months Ended September 30, 2025   Nine Months Ended September 30, 2024
   
   
   
Operating Activities:      
       
Net Income $ 21,439     $ 18,532  
       
Pension Contributions (Greater) than Expense   -       (25 )
Depreciation & Amortization   5,323       5,177  
Deferred Tax Expense   288       -  
(Gain) on Sales of Equipment   (42 )     (104 )
Loss (Gain) on Disposal of Equipment   647       (389 )
Change in Assets and Liabilities      
(Inc) in Accounts and Notes Receivable   (7,843 )     (6,197 )
(Inc) in Cost in Excess of Estimated Earnings and Billings   (870 )     -  
(Inc) Dec in Inventories   (5,976 )     738  
(Inc) in Prepayments   (4,752 )     (2,724 )
(Inc) in Net Investment in Sales-type leases   (754 )     (353 )
Dec in Other LT Assets   2,313       1,036  
(Dec) Inc in Accounts Payable   (126 )     1,962  
(Dec) in Accrued Income Tax   (443 )     (1,063 )
Inc in Other Accrued Expenses   1,295       1,606  
Inc (Dec) in Advanced Billings   12,611       (4,686 )
Inc in Billings in Excess of Costs and Estimated Earnings   3,190       5,842  
Inc in Lease Liability for Operating   -       169  
Principal payments of Lease Liability for Operating   (251 )     (188 )
Inc (Dec) in Long Term Deferred Tax Liabilities   24       (85 )
(Dec) Inc in Other Long-Term Liabilities   (1,739 )     (119 )
Net Cash Provided by Operating Activities $ 24,334     $ 19,129  
       
Investing Activities      
Purchases of Marketable Securities   (26,822 )     (16,442 )
Proceeds from Sales of Marketable Securities   22,923       29,403  
Proceeds from Sales of Equipment   42       131  
Additions to Property, Plant, and Equipment   (21,106 )     (8,637 )
Net Cash (Required) for Investing Activities $ (24,963 )   $ 4,455  
       
Financing Activities      
Principal payments of Lease Liability for Financing   (70 )     (149 )
(Repayment) of Short-Term Borrowings, Net   (5,186 )     (1,637 )
Proceeds of Short-Term Borrowings, Net   2,136       1,637  
(Repayment) of Long-Term Debt   (2,187 )     (1,152 )
Dividends Paid   (774 )     (594 )
Treasury Stock Acquisitions   (1,779 )     (11,910 )
Net Cash Provided by (Required for) Financing Activities $ (7,860 )   $ (13,805 )
       
Effect of Exchange Rate Changes   1,132       357  
       
Net (Decrease) Increase in Cash and Cash Equivalents $ (7,357 )   $ 10,136  
       
Cash and Cash Equivalents at Beginning of Year   21,169       5,894  
       
Cash and Cash Equivalents at End of Quarter $ 13,812     $ 16,030  
       

PAUL MUELLER COMPANY
SUMMARIZED NOTES TO THE FINANCIAL STATEMENTS
(In thousands)

A. The chart below depicts the net revenue on a consolidating basis for the three months ended September 30.

Three Months Ended September 30
Revenue   2025     2024  
Domestic $ 48,950   $ 52,560  
Mueller BV $ 12,442   $ 10,087  
Eliminations $ (17 ) $ (562 )
Net Revenue $ 61,375   $ 62,085  
     

The chart below depicts the net revenue on a consolidating basis for the nine months ended September 30.

     
Nine Months Ended September 30
Revenue   2025     2024  
Domestic $ 157,955   $ 144,267  
Mueller BV $ 35,021   $ 35,076  
Eliminations $ (117 ) $ (1,232 )
Net Revenue $ 192,859   $ 178,111  
     

The chart below depicts the net revenue on a consolidating basis for the twelve months ended September 30.

     
Twelve Months Ended September 30
Revenue   2025     2024  
Domestic $ 215,870   $ 187,349  
Mueller BV $ 47,903   $ 48,043  
Eliminations $ (440 ) $ (1,495 )
Net Revenue $ 263,333   $ 233,897  
     

The chart below depicts the net income (loss) on a consolidating basis for the three months ended September 30.

     
Three Months Ended September 30
Net Income   2025     2024  
Domestic $ 4,682   $ 7,365  
Mueller BV $ 208   $ (84 )
Eliminations $ (9 ) $ (2 )
Net Income (Loss) $ 4,881   $ 7,279  
     

The chart below depicts the net income on a consolidating basis for the nine months ended September 30.

     
Nine Months Ended September 30
Net Income   2025     2024  
Domestic $ 21,032   $ 17,440  
Mueller BV $ 408   $ 1,064  
Eliminations $ (2 ) $ 28  
Net Income (Loss) $ 21,438   $ 18,532  
     

The chart below depicts the net income on a consolidating basis for the twelve months ended September 30.

     
Twelve Months Ended September 30
Net Income   2025     2024  
Domestic $ 31,926   $ (8,121 )
Mueller BV $ 680   $ 2,775  
Eliminations $ (28 ) $ 4  
Net Income Loss $ 32,578   $ (5,342 )
     

B. September 30, 2025 backlog is $250.4 million compared to $171.5 million at September 30, 2024. The September 30, 2025 backlog has been reduced by $50.2 million as we received notice that a large pharmaceutical project is to be canceled and we anticipate the cancellation to be finalized in the fourth quarter. As a result, we are publishing the September 30, 2025 backlog with this project removed. We did, however, receive a purchase order for a $20 million project around the time we received the cancellation, which will help fill in our schedule primarily in 2026.

With the cancelled order removed, our U.S. backlog is $238.4 million, compared to $165.3 million at September 30, 2024. The increase in the U.S. backlog is primarily from pharmaceutical clients of the Industrial Equipment segment. In our European Operations, the September 30, 2025 backlog of $12.9 million has almost doubled from the September 30, 2024 backlog of $6.9 million.

C. Profits are down in the third quarter compared to the first two quarters of 2025. Most of our large projects are recorded using the over-time method of revenue recognition which recognizes revenue and profit based on either the cost or hours worked compared to the estimated total cost or hours to complete. In the third quarter, we fell behind on two large pharmaceutical jobs as we encountered some challenging fabrication tasks. We pulled resources from other areas of the company and increased outside contract labor to get back on schedule.

Although these projects are still profitable, this disruption in production in the third quarter caused us to change our opinion about the estimated cost of completing these two jobs. Since we use over-time revenue recognition, these adjustments in our estimate to completion had a negative effect on third quarter earnings.

D. We manage our business in the U.S. looking at earnings before tax (EBT) and excluding the effects of LIFO and non-reoccurring events such as the pension settlement. This non-GAAP adjusted EBT (as shown in the table below) is down over the prior year by $4.2 million for the three months ended September 30, but up $6.2 million for six months, and $12 million for the trailing twelve months primarily from strong results in the Industrial Equipment segment.

 
Results Ending September 30th
  Three Months Ended September 30   Nine Months Ended September 30   Twelve Months Ended September 30
(In Thousands)   2025     2024     2025   2024       2025     2024  
Domestic Net Income $ 4,682   $ 7,365   $ 21,032 $ 17,440     $ 31,926   $ (8,121 )
Income Tax Expense $ 1,411   $ 2,321   $ 6,331 $ 5,391     $ 9,092   $ (3,834 )
Domestic EBT - GAAP $ 6,093   $ 9,686   $ 27,363 $ 22,831     $ 41,018   $ (11,955 )
LIFO Adjustment $ (438 ) $ 151   $ 1,314 $ (312 )   $ (2 ) $ (770 )
Pension Adjustment $ -   $ -   $ - $ -     $ -   $ 41,774  
Domestic EBT - Non-GAAP $ 5,655   $ 9,837   $ 28,677 $ 22,519     $ 41,016   $ 29,049  
                                     

E. On October 24, 2025, the Company announced the board approved a tender offer at $485 per share that ends on November 21, 2025.

F. On October 24, 2025, the Company announced the board approved a thirty-cent dividend payable on December 29, 2025 to shareholders of record on November 26, 2025.

G. The consolidated financials are affected by the euro to dollar exchange rate when consolidating Mueller B.V., the Dutch subsidiary. The month-end euro to dollar exchange rate was 1.12 at September 2024; 1.04 at December 2024 and 1.17 for September 2025, respectively.

This press release contains forward-looking statements that provide current expectations of future events based on certain assumptions. All statements regarding future performance growth, conditions, or developments are forward-looking statements. Actual future results may differ materially from those described in the forward-looking statements due to a variety of factors, including, but not limited to, the factors described in the Company’s Annual Report under “Safe Harbor for Forward-Looking Statements”, which is available at paulmueller.com. The Company expressly disclaims any obligation or undertaking to update these forward-looking statements to reflect any future events or circumstances.

The accounting policies related to this report and additional management discussion and analysis are provided in the 2024 annual report, available at
www.paulmueller.com.

Press Contact: Ken Jeffries | Paul Mueller Company | Springfield, MO 65802 | (417) 575-9346
kjeffries@paulmueller.com | http://paulmueller.com


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions